BRICD5: A Potential Drug Target (G283870)

Target Name: BRICD5

NCBI ID: G283870

BRICD5

BRICD5: A Potential Drug Target

BRICD5 (chromosome 16 open reading frame 79) is a gene that encodes a protein involved in various cellular processes. The study of BRICD5 and its potential as a drug target has gained significant interest in recent years due to its unique structure and the involvement of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Structure and Function

BRICD5 is a member of the KIM (Kinesin-Light Chain) gene family, which is known for their involvement in the movement of chromosomes during cell division. The open reading frame (ORF) of BRICD5 contains 79 amino acid residues, with the first amino acid residue being a lysine residue, which is a common amino acid that plays a crucial role in protein structure and function.

The function of BRICD5 is not well understood, but research has shown that it is involved in various cellular processes, including cell adhesion, migration, and invasion. BRICD5 has also been shown to play a role in the development and progression of cancer, as well as in neurodegenerative diseases and autoimmune disorders.

Drug Target Potential

BRICD5 has been identified as a potential drug target due to its unique structure and the involvement of several diseases. The KIM gene family has been shown to be involved in various cellular processes, including the production of organelles that are essential for the function of cells. This suggests that BRICD5 may be involved in the production of organelles that are necessary for the function of cells.

BRICD5 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of cancer. The production of organelles that are necessary for the growth and development of cancer cells may be a potential target for BrICD5.

BRICD5 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of neurodegenerative diseases. The production of organelles that are necessary for the growth and development of neurodegenerative diseases may be a potential target for BrICD5.

BRICD5 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of autoimmune disorders. The production of organelles that are necessary for the growth and development of autoimmune disorders may be a potential target for BrICD5.

Conclusion

BRICD5 is a gene that encodes a protein involved in various cellular processes. Its unique structure and involvement in the KIM gene family make it a potential drug target. The study of BRICD5 and its potential as a drug target has gained significant interest in recent years, and further research is needed to fully understand its role in cellular processes and its potential as a drug target.

Protein Name: BRICHOS Domain Containing 5

The "BRICD5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BRICD5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets